Immune Therapy Project

Sean explains how the test is likely to impact “inpatient” treatment periods…
Sean explains the implications of the “test” and Keith emphasises the liberating effect of PLEX involvement…
Asked about metrics, Sean refers to the success of the MAPS approach in his own practice…
Renaud outlines his theory of the origins of empathy – much to the amusement of the others in the room…
The ZURICH team continue their discussion around DNA and microRNA methylation and touch on the reasons why it is so difficult to treat psychiatric disorders…
The meeting begins to get “technical” as Isabelle and Renaud discuss the markers and mechanisms involved in Transgenerational Epigenetic Inheritance (TEI)…
Isabelle reveals the advantages participating in SYNERGIES and Cecilia evokes the problems she has with taking her medication…
The ambition of the MAPS project is to match drugs and doses to patient metabolisms – Katie thinks that sounds too good to be true…
The group discusses the logistics of getting swabs and getting well…